WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

Intuitive wins a CE mark for adult cardiac surgery with da Vinci 5 FDA drafts surgical robot testing expectations and leaves autonomy out of scope Marani Health clears the M•care system for fetal and maternal monitoring at home FDA books December 2 and 3 for a workshop on robot autonomy and remote teleoperation Glytec wins Breakthrough designation for insulin dosing software in newborns Perfuze bench study puts Millipede88 first-pass success at 88 percent in MCA models Precision Neuroscience raises $250M Series D and takes total funding to $430M FDA calls BD's kit correction Class I over recalled saline ampules from a supplier FDA early alert flags a loose cable that reboots React Health VOCSN ventilators Intuitive wins a CE mark for adult cardiac surgery with da Vinci 5 FDA drafts surgical robot testing expectations and leaves autonomy out of scope Marani Health clears the M•care system for fetal and maternal monitoring at home FDA books December 2 and 3 for a workshop on robot autonomy and remote teleoperation Glytec wins Breakthrough designation for insulin dosing software in newborns Perfuze bench study puts Millipede88 first-pass success at 88 percent in MCA models Precision Neuroscience raises $250M Series D and takes total funding to $430M FDA calls BD's kit correction Class I over recalled saline ampules from a supplier FDA early alert flags a loose cable that reboots React Health VOCSN ventilators

Board

Shockwave founder Daniel Hawkins takes the board chair at Solenic Medical

MedDevice Startups Staff · 2 days ago · 2 min read · Via MassDevice

Daniel Hawkins is the new board chair at Solenic Medical. Hawkins founded Shockwave Medical and ran it as CEO from 2007 to 2017, after executive roles at Intuitive Surgical. J&J MedTech bought Shockwave for $13.1B in 2024.

Solenic, based in Dallas, treats periprosthetic joint infection with alternating magnetic fields. The system heats the outer surface of a metal implant enough to break up bacterial biofilm, which is meant to keep the implant in the patient. VIC Technology Venture Development formed the company in December 2019 around technology licensed from UT Southwestern.

FDA approved the company's IDE on June 23 for a trial of SOLA-2 in infected knee replacements, with enrollment expected to start in the second half of 2026. A chair with a $13B exit behind him is a financing signal as much as a governance one, and Solenic has a trial to fund.

Questions & Answers

Who is the new board chair of Solenic Medical?

Daniel Hawkins became board chair of Solenic Medical in September 2026. Hawkins founded Shockwave Medical and was its CEO from 2007 to 2017, and earlier held executive roles at Intuitive Surgical.

What does Solenic Medical's SOLA-2 system do?

SOLA-2 uses alternating magnetic fields to heat the outer surface of a metal orthopedic implant and disrupt bacterial biofilm. The aim is to treat periprosthetic joint infection without removing the implant.

What is the regulatory status of Solenic Medical's SOLA-2?

FDA approved Solenic Medical's investigational device exemption on June 23, 2026 for a trial of SOLA-2 in patients with infected knee replacements. The company expected enrollment to begin in the second half of 2026.

← Back to Startups